Jaguar Health, Inc. (JAGX): Nasdaq/NYSE listing notice — Jaguar Health receives Nasdaq delisting notice for bid price below $0.10 for 10 days

Jaguar Health, Inc.

Nasdaq notified Jaguar Health on Jan 5, 2023 that its common stock bid price closed below $0.10 for 10 consecutive trading days, triggering delisting under Rule 5810(c)(3)(A)(iii).
Company intends to request a hearing before the Nasdaq Hearings Panel to appeal; request will stay delisting pending hearing and potential extension.
Jaguar Health also must regain compliance with $1.00 minimum bid price rule by Feb 13, 2023, having been granted a 180-day grace period.
Special stockholder meeting scheduled for Jan 20, 2023 to vote on reverse stock split (ratio of 1-for-3 to 1-for-75) to potentially regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Jaguar Health, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(3)(A)(iii)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5810(3)(A)(iii)

Exact text from the filing

January 5, 2023, Jaguar Health, Inc. (the “Company”) received notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the bid price for the Company’s voting common stock, par value $0.0001 per share (the “Common Stock”), had closed below $0.10 per share for the preceding ten consecutive trading days, in contravention of Nasdaq Listing Rule 5810(3)(A)(iii) (the “$0.10 Rule”), the Company’s securities were subject to delisting unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”) to appea

View on SEC.gov

Browse all listing & compliance notices →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-001912

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.